It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The biological significance of micro (mi)RNAs has traditionally been evaluated according to their RNA expression levels based on the assumption that miRNAs recognize and regulate their targets in an unvarying fashion. Here we show that a fraction of mature miRNAs including miR-17-5p, -21-5p, and -200c-3p and let-7a-5p harbor methyl marks that potentially alter their stability and target recognition. Importantly, methylation of these miRNAs was significantly increased in cancer tissues as compared to paired normal tissues. Furthermore, miR-17-5p methylation level in serum samples distinguished early pancreatic cancer patients from healthy controls with extremely high sensitivity and specificity. These findings provide a basis for diagnostic strategies for early-stage cancer and add a dimension to our understanding of miRNA biology.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Koseki, Jun 2 ; Asai, Ayumu 3 ; Yamagata, Akira 4 ; Shimamura, Teppei 5 ; Motooka, Daisuke 6 ; Okuzaki, Daisuke 6
; Kawamoto, Koichi 7 ; Mizushima, Tsunekazu 7 ; Eguchi, Hidetoshi 7 ; Takiguchi, Shuji 8 ; Satoh, Taroh 1 ; Mimori, Koshi 9 ; Ochiya, Takahiro 10 ; Doki, Yuichiro 7 ; Ofusa, Ken 4 ; Mori, Masaki 7 ; Ishii, Hideshi 2 1 Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
2 Department of Cancer Profiling Discovery/ Medical Data Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
3 Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; Department of Cancer Profiling Discovery/ Medical Data Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
4 Prophoenix Division, Food and Life-Science Laboratory, Idea Consultants, Inc., Osaka-city, Osaka, Japan
5 Division of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
6 Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
7 Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
8 Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Aichi, Japan
9 Department of Surgery, Kyushu University Beppu Hospital, Beppu, Oita, Japan
10 Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan




